Clinical Trial

Efficacy of CL22205 to Improve Menstrual Discomfort and Quality of Life

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 7, 2025 (before its estimated October 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy of CL22205 to improve menstrual discomfort and quality of life in oligomenorrheic female subjects.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-04; most recent amendment 2025-03-04.
Trial Details
NCT Number NCT06760988
Lead Sponsor Eetho Brands, Inc
Conditions Menstrual Discomfort
Enrollment 80 participants
Start Date 2025-02-24
Primary Completion 2025-10-05 (estimated)
Study Completion 2026-01-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-07